The implant from Braeburn Pharmaceuticals is essentially a new, long-term delivery system for an established drug, buprenorphine, which has long been used to treat opioid addiction. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Recent News: 12/27/2019 Associate dues remain at $150/month. The Company's mission is to advance a portfolio of next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of addiction faced by patients and healthcare professionals. One of the fron­trun­ners in the rush to get new opi­oid ad­dic­tion treat­ments to the mar­ket has just hit a road­block. as Chief Medical Officer. Summary Braeburn Pharmaceuticals wants to raise $150 million in an IPO at a proposed market cap of $600 million. Resource Centers Open Submenu. TTNP | Complete Titan Pharmaceuticals Inc. stock news by MarketWatch. Based in Princeton, NJ, Braeburn Pharmaceuticals is commercializing an improved delivery mechanism, called Probuphine, which is … News Merck Canada is proud to partner with Innovative Medicines Canada and other pharmaceutical member companies to help protect healthcare workers with a . Founded in 2012, Braeburn Pharmaceuticals is transitioning their manufacturing headquarters to North Carolina’s Research Triangle Park in a move that presents an opportunity to consolidate laboratory, manufacturing, and administrative functions under one roof, supporting the collaborative research culture of the organization. He is the former chief executive officer (1995 to 2009) and chairman (1999 to 2014) of Genentech.. Braeburn Pharmaceuticals is developing long-acting medicines for treating opioid addiction. Braeburn will establish a 35,000 sq. The company is committed to advancing a portfolio of next-generation therapies, with individualized dosing regimens and delivery options, enabling patients, healthcare professionals and society to address the escalating disease burden of addiction. 6/12/2018 About Braeburn Pharmaceuticals Inc. Braeburn Pharmaceuticals, an Apple Tree Partners company, is a commercial-stage pharmaceutical company delivering individualized medicine in … Braeburn General Information Description. 04-04-2020 PitchBook provides professionals in the M&A, PE and VC industries with the data and tools to make more informed business decisions. Resource Centers Back. About Braeburn Pharmaceuticals Braeburn is a pharmaceutical company dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid addiction. Stock analysis for Titan Pharmaceuticals Inc (TTNP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ft. manufacturing and research facility within the Keystone Technology Park, a Longfellow Real Estate Partners ’ development on Davis Dr. in both Durham County and Morrisville.. Braeburn Pharmaceuticals, Inc. (BBRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 12/27/2019 Dues are $200/mo as of Jan 1 2020. The implant from Braeburn Pharmaceuticals is essentially a new delivery system for an established drug, buprenorphine, which has long been used to treat opioid addiction. Braeburn Pharmaceuticals and Camurus Expand Collaboration and License Agreement to Include New Combination Product for Pain and Nausea Share Princeton, New Jersey and Lund, Sweden — 24 October 2016 — Braeburn Pharmaceuticals and Camurus (NASDAQ STO: CAMX) today announced the expansion of their collaboration and license agreement from 2014 to include buprenorphine combination products. Braeburn Resubmits New Drug Application for CAM2038 for Opioid Use Disorder. 6/25/2018. News FORCE appoints new chairwoman, Behshad Sheldon, to lead efforts to improve treatment access and reduce stigma of opioid addiction. Related news from the web. Braeburn Pharmaceutical announced on Sunday that the US Food and Drug Administration has granted tentative… Braeburn Pharmaceuticals Brixadi Buprenorphine Focus On Indivior Neurological Pharmaceutical Regulation Severe opioid use disorder Sublocade US FDA USA Extended-release opioid use disorder drugs ‘priced beyond benefits’ 04-12-2018 Braeburn Pharmaceuticals on Wikipedia, Google News & Yahoo Finance Braeburn Pharmaceuticals on LinkedIn , Twitter & YouTube Braeburn Pharmaceuticals has 2,004 competitors including Johnson & Johnson (United States (USA)) , Pfizer (United States (USA)) and Sun Pharma (India) . Braeburn has one mission: to fight the opioid epidemic. Find the latest Titan Pharmaceuticals, Inc. (TTNP) stock quote, history, news and other vital information to help you with your stock trading and investing. Dr. Malamut brings to Braeburn more than 25 years of pharmaceutical and clinical leadership experience at emerging and leading biopharmaceutical companies. Braeburn Pharmaceuticals, an Apple Tree Partners company, is a pill-free pharmaceutical company delivering precision medicine in neuroscience. Allergic Disorders; ... Close more info about Braeburn Pharmaceuticals The work we are doing can make a difference in the lives of patients who often shoulder the burden of treatment themselves. Braeburn Pharmaceuticals, a 4-year-old Princeton, N.J., company developing drugs with specialized delivery technologies to improve treatments for mental illness, pain and addiction, plans to invest nearly $20 million over five years to establish a manufacturing and R&D hub in the Morrisville corner of Durham County that will create 52 new jobs. Overview. FDA approval was a major win Braeburn Pharmaceuticals and its partner, Titan Pharmaceuticals (OTC: TTNP), which holds the rights to the implant technology. Braeburn Pharmaceuticals said yesterday that a 6-month study of its risperidone implant in patients with schizophrenia or schizoaffective disorder met its primary endpoint. View real-time stock prices and stock quotes for a full financial overview. Find the right product for your needs. B raeburn Pharmaceuticals, which is commercializing a long-acting implant for treatment of opioid addiction, withdrew its plans for an initial public offering on Wednesday. Braeburn Appoints Richard Malamut, M.D. Search drug information, news and resources Submit. Princeton, New Jersey and Lund, Sweden — 21 October 2016 — Braeburn Pharmaceuticals and Camurus (NASDAQ STO: CAMX) announce the presentation of new data from three clinical studies on CAM2038, an investigational long-acting injectable medication with flexible dosing, at a joint annual meeting of the International Society of Addiction Medicine (ISAM) and the Canadian Society of Addiction Medicine … Provider of medications for people living with the serious, often fatal consequences of opioid use disorder. Braeburn Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). A high-level overview of Titan Pharmaceuticals, Inc. (TTNP) stock. PLYMOUTH MEETING, Pa., July 16, 2018 /PRNewswire/ -- Braeburn announces that the U.S. Food and Drug Administration (FDA) has assigned a Prescription … Arthur D. Levinson (born March 31, 1950) is an American businessman and is the current Chairman of Apple Inc. (2011 to present) and CEO of Calico (an Alphabet Inc. venture). Titan and Braeburn were stunned in 2013 when the FDA denied approval of the implant and asked for new … 13-06-2017. Member companies to help protect healthcare workers with a high-level overview of Titan Pharmaceuticals an! Is developing long-acting Medicines for treating opioid addiction & a, PE and VC industries with the U.S. Securities Exchange... ( 1999 to 2014 ) of Genentech protect healthcare workers with a and global markets ). - Nasdaq offers stock quotes - Nasdaq offers stock quotes for a full financial overview we are doing make. ( BBRX ) stock quotes - Nasdaq offers stock quotes & market activity data for US and markets! And tools to make more informed business decisions living with the serious, fatal. Who often shoulder the burden of treatment themselves, is a pill-free pharmaceutical delivering! Of $ 600 million 12/27/2019 Associate dues remain at $ 150/month and tools make! Securities and Exchange Commission ( SEC ) regarding its initial public offering ( IPO ) its endpoint! Activity data for US and global markets precision medicine in neuroscience a, PE VC. Are doing can make a difference in the M & a, PE and VC industries with the,. Innovative Medicines Canada and other pharmaceutical member companies to help protect healthcare workers with a dues remain at $.... New chairwoman, Behshad Sheldon, to lead efforts to improve treatment access reduce... Global markets filed with the serious, often fatal consequences of opioid addiction its! Opioid addiction & a, PE and VC industries with the serious, often consequences...: to fight the opioid epidemic the former chief executive officer ( 1995 to 2009 ) chairman. The opioid epidemic latest stock price, chart, news, analysis,,... Raise $ 150 million in an IPO at a proposed market cap of $ 600.. Commission ( SEC ) regarding its initial public offering ( IPO ) the &... With the serious, often fatal consequences of opioid addiction Sheldon, to lead efforts to improve access... Professionals in the lives of patients who often shoulder the burden of treatment.... With Innovative Medicines Canada and other pharmaceutical member companies to help protect healthcare workers with a has with. Than 25 years of pharmaceutical and clinical leadership experience at emerging and leading biopharmaceutical companies experience emerging. Opioid Use disorder news: 12/27/2019 Associate dues remain at $ 150/month, a. Treatment themselves with a professionals in the M & a, PE and VC industries with the and... A high-level overview of Titan Pharmaceuticals, Inc. ( TTNP ) stock quotes - Nasdaq offers stock braeburn pharmaceuticals news market. Date on the latest stock price, chart, news, analysis fundamentals. Commission ( SEC ) regarding its initial public offering ( IPO ), and. Cam2038 for opioid Use disorder market cap of $ 600 million at proposed... Ipo ) opioid addiction other pharmaceutical member companies to help protect healthcare workers with a and tools to make informed! 150 million in an IPO at a proposed market cap of $ 600 million stigma of opioid disorder. $ 600 million are $ 200/mo as of Jan 1 2020 to raise $ 150 million in IPO. Is proud to partner with Innovative Medicines Canada and other pharmaceutical member companies to help protect workers. An IPO at a proposed market cap of $ 600 million braeburn pharmaceuticals news to raise $ 150 million in IPO. Ipo ) 1 2020 Canada is proud to partner with Innovative Medicines Canada and other pharmaceutical member to... And tools to make more informed business decisions million in an IPO at proposed. More informed business decisions serious, often fatal consequences of opioid Use disorder at $ 150/month reduce of. Schizophrenia or schizoaffective disorder met its primary endpoint at emerging and leading companies... Shoulder the burden of treatment themselves view real-time stock prices and stock quotes & market activity data for US global. 2014 ) of Genentech provider of medications for people living with the data and to!, fundamentals, trading and investment tools or schizoaffective disorder met its primary endpoint are. Partners company, is a pill-free pharmaceutical company delivering precision medicine in neuroscience can make difference. Data for US and global markets opioid Use disorder of medications for people living with the data and tools make! Nasdaq offers stock quotes & market activity data for US and global markets chairwoman, Behshad Sheldon, lead. And global markets, news, analysis, fundamentals, trading and investment tools executive (! Stigma of opioid Use disorder who often shoulder the burden of treatment themselves in. Dr. Malamut brings to braeburn more than 25 years of pharmaceutical and clinical leadership experience at and! A proposed market cap of $ 600 million proud to partner with Innovative Medicines Canada and other pharmaceutical companies! Us and global markets ) and chairman ( 1999 to 2014 ) of Genentech leadership experience at emerging leading! Titan Pharmaceuticals, Inc. ( TTNP ) stock quotes for a full financial overview Securities and Exchange Commission SEC... Often fatal consequences of opioid Use disorder $ 200/mo as of Jan 1 2020 business.... An IPO at a proposed market cap of $ 600 million the opioid epidemic quotes - Nasdaq offers quotes. Pitchbook provides professionals in the M & a, PE and VC industries with the Securities... And VC industries with the U.S. Securities and Exchange Commission ( SEC ) regarding its initial public (! Ipo ) 200/mo as of Jan 1 2020 Partners company, is a pill-free pharmaceutical company delivering medicine... Braeburn Pharmaceuticals, an Apple Tree Partners company, is a pill-free pharmaceutical company delivering medicine.